HealthStream (NASDAQ:HSTM) Price Target Raised to $32.00

HealthStream (NASDAQ:HSTM) had its price objective boosted by investment analysts at Canaccord Genuity Group from $29.00 to $32.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a “hold” rating on the technology company’s stock. Canaccord Genuity Group‘s price target would suggest a potential downside of 1.48% from the company’s previous close.

HSTM has been the topic of a number of other research reports. Craig Hallum cut shares of HealthStream from a “buy” rating to a “hold” rating and set a $40.00 price target on the stock. in a report on Tuesday. Freedom Capital raised HealthStream to a “hold” rating in a research report on Tuesday, October 13th. Wall Street Zen upgraded HealthStream from a “hold” rating to a “buy” rating in a research note on Saturday. Weiss Ratings raised HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Finally, Citigroup reiterated a “market perform” rating on shares of HealthStream in a research note on Tuesday, October 27th. One research analyst has rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $36.00.

HealthStream Price Performance

Shares of NASDAQ:HSTM traded up $0.81 during trading on Wednesday, reaching $32.48. 310,382 shares of the stock were exchanged, compared to its average volume of 253,748. HealthStream has a 1-year low of $19.50 and a 1-year high of $35.60. The stock has a fifty day moving average of $31.11 and a two-hundred day moving average of $25.70. The firm has a market cap of $949.07 million, a price-to-earnings ratio of 46.40, a price-to-earnings-growth ratio of 4.00 and a beta of 0.45.

HealthStream (NASDAQ:HSTM) last issued its earnings results on Monday, November 2nd. The technology company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.02. HealthStream had a return on equity of 6.58% and a net margin of 6.25%. The company had revenue of $83.31 million for the quarter, compared to analysts’ expectations of $82.24 million. Sell-side analysts forecast that HealthStream will post 0.72 EPS for the current year.

Insiders Place Their Bets

In other HealthStream news, CEO Robert Frist, Jr. sold 144,068 shares of the stock in a transaction on Monday, September 14th. The stock was sold at an average price of $29.50, for a total transaction of $4,250,006.00. Following the sale, the chief executive officer owned 3,907,038 shares in the company, valued at $115,257,621. This represents a 3.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Linda Rebrovick sold 12,000 shares of HealthStream stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $35.00, for a total value of $420,000.00. Following the completion of the transaction, the director owned 39,329 shares of the company’s stock, valued at approximately $1,376,515. This trade represents a 23.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 20.40% of the company’s stock.

Institutional Investors Weigh In On HealthStream

Several large investors have recently added to or reduced their stakes in HSTM. BlackRock Inc. purchased a new position in shares of HealthStream during the second quarter worth about $111,184,000. Dimensional Fund Advisors LP raised its stake in HealthStream by 6.4% in the first quarter. Dimensional Fund Advisors LP now owns 1,456,043 shares of the technology company’s stock valued at $30,156,000 after purchasing an additional 87,177 shares in the last quarter. Copeland Capital Management LLC raised its stake in HealthStream by 43.8% in the first quarter. Copeland Capital Management LLC now owns 1,276,739 shares of the technology company’s stock valued at $26,441,000 after purchasing an additional 389,186 shares in the last quarter. Renaissance Technologies LLC lifted its position in HealthStream by 0.5% during the first quarter. Renaissance Technologies LLC now owns 477,848 shares of the technology company’s stock valued at $9,896,000 after purchasing an additional 2,380 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its position in HealthStream by 21.1% during the first quarter. Arrowstreet Capital Limited Partnership now owns 377,945 shares of the technology company’s stock valued at $7,827,000 after purchasing an additional 65,806 shares during the last quarter. Institutional investors own 69.58% of the company’s stock.

HealthStream News Summary

Here are the key news stories impacting HealthStream this week:

• Positive Sentiment: HealthStream reported Q3 EPS of $0.18 and revenue of $83.3 million, above estimates of about $0.15–$0.16 per share and $82.2 million, respectively. HealthStream Q3 Earnings and Revenues Surpass Estimates
• Positive Sentiment: The company forecast 2026 revenue of $331 million to $333 million, above the $329.5 million consensus estimate, while continuing its suite-and-bundle strategy. HealthStream forecasts 2026 revenue and advances suite-and-bundle strategy
• Neutral Sentiment: HealthStream declared a quarterly dividend of $0.035 per share, equivalent to $0.14 annualized and a yield of about 0.4%; this provides a modest shareholder return but is unlikely to be a major share-price catalyst. HealthStream declares dividend
• Negative Sentiment: Despite beating estimates, Q3 results drew attention to a margin squeeze, which may temper enthusiasm about the earnings beat and outlook. HealthStream stock drops after Q3 earnings margin squeeze
• Negative Sentiment: Craig-Hallum lowered its rating from Buy to Hold, citing high valuation. Its $40 price target remains above the referenced share price, but the downgrade signals caution about valuation. HealthStream downgraded on high valuation

About HealthStream

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.

The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.